Eric H. Yang, MD, emphasizes the need for collaboration and interventions to protect patients’ hearts during breast cancer treatment. Watch part 1 to learn which breast cancer therapies carry the ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown ...
Share on Pinterest Even occasional smoking can significantly raise heart disease risk. Mal de Ojo Studio/Stocksy Researchers say that smoking as few as two cigarettes a day can significantly increase ...
Please provide your email address to receive an email when new articles are posted on . Evolocumab is the first PCSK9 inhibitor to demonstrate effectiveness in primary and secondary prevention ...
The American College of Cardiology (ACC) and OpenEvidence are entering a strategic partnership to accelerate the translation of cardiovascular clinical guidance and research into clinical ...
Beth Skwarecki is Lifehacker’s Senior Health Editor and has been writing about health, fitness, and science here since 2015. Beth was the recipient of the 2017 Carnegie Science Award in science ...
View post: 'Game of Thrones' Star to Attempt Record-Breaking Deadlift at 2026 Enhanced Games View post: Garrison Brothers’ New Bourbon Is 146.4 Proof. Can You Handle the Heat of This 'Hazmat Whiskey?' ...
An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in people who took Wegovy. By Dani Blum A new analysis of a major clinical trial ...
Gregory Payne, M.D., Ph.D., associate professor in the UAB Division of Cardiovascular Disease, has been appointed director of the UAB Comprehensive Cardiovascular Center, a university-wide ...
Novartis is paying $1.4 billion to get its hands on Tourmaline Bio and its former Pfizer cardiovascular drug that impressed in a phase 2 study earlier this year. At the center of the deal is ...
While a recent head-to-head trial of the obesity med heavyweights Wegovy and Zepbound favored the latter drug from Eli Lilly on weight loss, Novo Nordisk has now countered that result with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback